Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil P Shah

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Journal of Graduate Medical Education|February 25, 2020
The Molecular Medicine Investigation Unit: Linking Patient Care and Scientific Inquiry in Physician-Scientist TrainingAmy Berger, Mehrdad Matloubian, Neil P Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceMichael R Burgess, Brian J Skaggs, Neil P Shah, et al.
Science (New York, N.Y.)|July 17, 2004
Overriding imatinib resistance with a novel ABL kinase inhibitorNeil P Shah, Chris Tran, Francis Y Lee, et al.
Clinical Pharmacology : Advances and Applications|June 22, 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III studyXiaoning Wang, Amit Roy, Andreas Hochhaus, et al.
Journal of Molecular Biology|April 11, 2025
Resistance to Allosteric InhibitorsIan R Outhwaite, Isabelle Kwan, Ariel Leyte-Vidal, et al.
Leukemia|June 25, 2026
Immunological mechanisms and therapeutic advances in chronic myeloid leukemiaTiffany K Ybarra, Ryan S Sathianathen, Rohaum Hamidi, et al.
Journal of Acupuncture and Meridian Studies|December 20, 2023
Acupuncture in Sports MedicineGeorge G A Pujalte, Michael Malone, Akhil Mandavalli, et al.
Nature|July 1, 2005
Dynamics of chronic myeloid leukaemiaFranziska Michor, Timothy P Hughes, Yoh Iwasa, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Scientific Reports|July 2, 2017
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cellsJonathan Metts, Heath L Bradley, Zhengqi Wang, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Journal of Graduate Medical Education|February 25, 2020
The Molecular Medicine Investigation Unit: Linking Patient Care and Scientific Inquiry in Physician-Scientist TrainingAmy Berger, Mehrdad Matloubian, Neil P Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2005
Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistanceMichael R Burgess, Brian J Skaggs, Neil P Shah, et al.
Science (New York, N.Y.)|July 17, 2004
Overriding imatinib resistance with a novel ABL kinase inhibitorNeil P Shah, Chris Tran, Francis Y Lee, et al.
Clinical Pharmacology : Advances and Applications|June 22, 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III studyXiaoning Wang, Amit Roy, Andreas Hochhaus, et al.
Journal of Molecular Biology|April 11, 2025
Resistance to Allosteric InhibitorsIan R Outhwaite, Isabelle Kwan, Ariel Leyte-Vidal, et al.
Leukemia|June 25, 2026
Immunological mechanisms and therapeutic advances in chronic myeloid leukemiaTiffany K Ybarra, Ryan S Sathianathen, Rohaum Hamidi, et al.
Journal of Acupuncture and Meridian Studies|December 20, 2023
Acupuncture in Sports MedicineGeorge G A Pujalte, Michael Malone, Akhil Mandavalli, et al.
Nature|July 1, 2005
Dynamics of chronic myeloid leukaemiaFranziska Michor, Timothy P Hughes, Yoh Iwasa, et al.
Blood|September 4, 2004
Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatmentSu Chu, Helen Xu, Neil P Shah, et al.
Scientific Reports|July 2, 2017
Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cellsJonathan Metts, Heath L Bradley, Zhengqi Wang, et al.
Pageof 12